FIELD: medicine.
SUBSTANCE: invention relates to industrial microbiology, namely to a method of obtaining a composition, intended for prevention of a cow milk protein allergy (CMPA) and a higher sensitivity to allergens in newborn babies and infants. The method includes a stage of milk substrate bioconversion by means of a culture of Bifidobacterium breve BBC50 strain, deposited on May 31 1999 in the National Collection of Cultures of Microorganisms (CNCM) under the number I-2219, by keeping a substrate in contact with the strain culture under conditions unfavourable for production of an acid by the strain.
EFFECT: application of the claimed method makes it possible to obtain the composition, efficient for prevention of the allergy to cow milk proteins and a higher sensitivity to allergens in newborn babies and infants.
10 cl, 5 dwg, 1 ex
